Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ADMA Biologics Q4 2023 Adj EPS $0.04 Beats $0.03 Estimate, Sales $73.90M Beat $72.15M Estimate

Author: Benzinga Newsdesk | February 28, 2024 05:28pm
ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. The company reported quarterly sales of $73.90 million which beat the analyst consensus estimate of $72.15 million by 2.43 percent. This is a 47.86 percent increase over sales of $49.98 million the same period last year.

Posted In: ADMA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist